Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

784 results about "Hemoglobin H" patented technology

Cognitive state classification method based on EEG-fNIRS deep fusion of feature decoupling

The invention discloses an EEG-fNIRS deep fusion cognitive state classification method based on feature decoupling, and the method comprises the steps: firstly synchronously collecting EEG data and fNIRS data of a tested mental calculation task, and carrying out the preprocessing of the two collected data, so as to obtain EEG data and hemoglobin concentration change data; secondly, electroencephalogram signal data and hemoglobin concentration change data are taken, data enhancement is carried out through a time window, then the data are sent to a deep fusion network, and public features and private features of EEG and primary features of fNIRS are obtained; and an EEG classification result, an fNIRS classification result and an output fusion classification result are obtained. And finally, designing decoupling loss and cross entropy loss based on a label smoothing strategy, and carrying out training. According to the method, the overfitting problem in fNIRS modal deep learning is effectively relieved, and cognitive state classification can be accurately carried out.
Owner:HANGZHOU DIANZI UNIV

Nano enzyme as well as preparation method and application thereof

The invention provides a nano enzyme as well as a preparation method and application thereof. The preparation method of the nano enzyme comprises the following steps: adding a stabilizer into a preheated solvent, and carrying out ultrasonic treatment; then adding ferric salt and cobalt salt, and adding alkali to adjust the pH value of the solution; then transferring the solution into a reaction kettle for reaction; and after the reaction, washing and separating to obtain the product. The obtained nano-enzyme is appropriate and uniform in particle size and good in dispersity, the enzyme activity is as high as 9.56 U / mg, and the application of the nano-enzyme in immunochromatography detection and plant canker prevention and treatment is widened. When the immunochromatography detection card prepared from the nano enzyme is used for detecting human hemoglobin, the detection limit can reach 0.05 ng / mL and is at least 10 times lower than that of a commercially available kit. When the nano-enzyme suspension is used for preventing and treating the kiwifruit canker, the nano-enzyme suspension with the concentration larger than or equal to 0.1 mg / mL is used, and the plant canker can be well controlled.
Owner:CHONGQING KANGJU QUANHONG BIOTECHNOLOGY CO

Electrophysiology and hemodynamics multi-mode intelligent wearable system and data evaluation method

The invention discloses an electrophysiology and hemodynamics multi-mode intelligent wearable system and a data evaluation method, and belongs to the technical field of biomedical engineering, the system comprises an optical module, a flexible stretchable electric signal module and a central module; the optical module is used for collecting hemodynamic signals including an oxyhemoglobin change signal, a deoxygenated hemoglobin change signal and a pulse wave signal by combining a near-infrared light signal with hemodynamics; the flexible stretchable electric signal module collects electric signals, including electroencephalogram signals, electromyographic signals, electrocardiosignals and electro-oculogram signals, of all parts through electrodes; the central module is used for digitalizing and preprocessing the hemodynamic signal and the electric signal of each part, fusing multi-modal data, evaluating data quality and predicting a dominant external event influencing the data quality; and meanwhile, data quality and dominant external events are output to the terminal to feed back and adjust acquisition parameters of the optical module and the flexible stretchable electric signal module, so that the effectiveness and practicability of monitoring are remarkably improved.
Owner:HANGZHOU RONGNAO TECHNOLOGY CO LTD

Hemoglobin-resistant Taq DNA polymerase mutant and construction method thereof

The invention discloses a hemoglobin-resistant Taq DNA polymerase mutant and a construction method thereof, and relates to the field of biology, and the hemoglobin-resistant Taq DNA polymerase mutant is characterized in that a nucleotide sequence for coding the Taq DNA polymerase is shown as SEQ ID NO.1, and the mutant comprises at least one mutation or all mutations selected from S623D and E721A sites. On the basis of natural Taq DNA polymerase, the molecular structure of the Taq DNA polymerase is modified through rational design and combination with a site-specific mutagenesis biotechnology, so that the Taq DNA polymerase mutant is more suitable for PCR amplification of samples containing hemoglobin and the like than a wild type, and the result judgment accuracy of a sample containing a hemoglobin inhibitor is more facilitated.
Owner:WUXI CHENGYUAN BIOTECHNOLOGY CO LTD +1

Exosome, mesenchymal stem cell and application of exosome and mesenchymal stem cell in treatment of type 2 diabetes mellitus

The invention provides an exosome, a mesenchymal stem cell and application of the exosome and the mesenchymal stem cell in treatment of type 2 diabetes mellitus, and belongs to the technical field of biological medicine. The exosome secreted by the umbilical cord mesenchymal stem cells of the composite pretreatment group is used for treating the type 2 diabetes mellitus, and the obvious advantages are shown. Compared with a model control group, the exosome has the advantages that the glucose tolerance of diabetic rats treated by the exosome is obviously improved, the blood glucose value is reduced by about 47.5% within 120 minutes, the area under a blood glucose curve (AUC) is reduced by about 50.5%, the serum insulin is increased by about 147.7%, insulin secretion is effectively promoted, the glycosylated hemoglobin level is obviously reduced, and the long-term blood glucose control effect is good. By integrating various indexes, the exosome obtained by the composite pretreatment scheme provided by the invention has a remarkable effect of improving the illness state of rats with type 2 diabetes mellitus, provides a new effective strategy for treatment of type 2 diabetes mellitus, and shows a good application prospect.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV +1

Abdominal aortic aneurysm progress prediction method and system based on cross-modal knowledge distillation

The invention discloses an abdominal aortic aneurysm progress prediction method and system based on cross-modal knowledge distillation. The method comprises the following steps: collecting blood of a target object; the method comprises the following steps: detecting the concentration of blood protein fingerprint markers of blood of a target object, wherein the blood protein fingerprint markers comprise matrix metalloproteinase-12, calcitonin-related polypeptide-alpha, uromodulin, nerve injury induction protein-1, glycosylated hemoglobin A1c and fibroblast growth factor-9; carrying out abdominal aortic aneurysm risk calculation by calling Student-net of cross-modal knowledge distillation based on the blood protein fingerprint marker concentration; wherein the input of the Teaser-net of the cross-modal knowledge distillation comprises a CTA image feature and a pathological section feature, and a category probability vector output by the Student-net is aligned with a category probability vector output by the Teaser-net; and outputting the risk level of the abdominal aortic aneurysm and the probability of occurrence / progress / rupture of the abdominal aortic aneurysm in the preset year. And the development of the aortic aneurysm disease is accurately predicted.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Diabetic complication monitoring auxiliary system and method thereof

The invention discloses a diabetic complication monitoring auxiliary system and method in the technical field of complication monitoring, and the system comprises a data collection module which is used for obtaining local multi-modal data of a user in real time; the federal learning module is used for integrating the local multi-modal data of the user with other anonymous medical databases through a distributed architecture and constructing a multi-family cross-institution complication prediction model; the causal reasoning module is used for analyzing the causal relationship among the blood glucose fluctuation, the glycosylated hemoglobin and the target complication based on an anti-factual causal reasoning algorithm, and outputting a causal effect value to correct the prediction deviation; the prediction module is used for generating occurrence probabilities of future specific complications based on the causal effect values and risk scores output by the complication prediction model, and classifying the occurrence probabilities according to risk levels; and the early warning module is used for generating personalized intervention suggestions according to the risk levels. According to the scheme, the data leakage risk in the data acquisition process is reduced through the federal learning distributed architecture, and the prediction reliability is improved.
Owner:DONGGUAN HOUJIE HOSPITAL (DONGGUAN EMERGENCY HOSPITAL)

Gene editing systems and compositions for treatment of hemoglobinopathies and methods of using the same

The present disclosure describes improved LNP-based nucleobase editing systems and therapeutics for use in treating hemoglobinopathies, including sickle cell disease and beta-thalassemia. In particular, the disclosure describes improved LNPs, including novel and improved ionizable lipids for making LNPs, that enhance the targeted delivery of LNP-based nucleobase editing systems and therapeutics to red blood cell progenitor cells, enabling treatment of hemoglobinopathies, in vivo.
Owner:RENAGADE THERAPEUTICS MANAGEMENT INC

Peritoneal drainage system based on hemoglobin real-time monitoring and intelligent early warning

The invention relates to the technical field of peritoneal drainage, in particular to a peritoneal drainage system based on hemoglobin real-time monitoring and intelligent early warning. According to the technical scheme, the device comprises an abdominal cavity drainage tube, an optical sensing module, a microprocessor module and a wireless communication module, wherein the microprocessor module is configured to perform moving average filtering and dynamic trend modeling on hemoglobin concentration data; and triggering early warning according to a preset multi-level alarm condition. The hemoglobin concentration in the peritoneal drainage liquid is accurately monitored in real time, intelligent early warning and a personalized response mechanism are combined, the limitation of traditional manual observation is broken through, the timeliness and accuracy of bleeding risk identification are remarkably improved, the infection risk is reduced through the closed design, the medical care working process is optimized through the system integration capacity, and the medical care efficiency is improved. Data sharing and remote cooperation are achieved, intervention time windows are shortened, patient prognosis is improved, nursing resources can be released, medical quality is improved, and a comprehensive and efficient solution is provided for postoperative monitoring.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL

Novel wound dressing as well as preparation method and application thereof

ActiveCN119033998AImprove binding efficiencyovercome interfacial tensionBandagesDiseaseIschemic ulcer
The invention belongs to the field of surface skin repair and wound treatment, and particularly relates to a novel wound dressing as well as a preparation method and application thereof. The preparation method comprises the following steps: preparation and preliminary purification of hemoglobin, fine purification of hemoglobin, degassing treatment, virus inactivation, preparation of a wound dressing stock solution and preparation of the wound dressing. The wound dressing can be used in the treatment of wounds on the skin surface, in particular in the treatment of chronic wounds, in particular in the treatment of chronic wounds with delayed healing for more than 8 weeks, in particular in the treatment of chronic wounds with delayed healing for more than 8 weeks. The ulcers comprise diabetes mellitus, nerve or ischemic ulcers, ulcers caused by leg vein insufficiency, ulcers (such as pressure sores and bedsores) caused by external pressure after skin and tissue aging, second-level and lower burns, chilblain and the like, and particularly foot ulcers caused by diabetes mellitus; the composition can be used for repairing scars on the skin surface and repairing refractory wounds after an operation.
Owner:REDPHARM BEIJING BIOPHARMACEUTICAL INST CO LTD +2

Cosmetic instrument control method and system

The invention relates to the technical field of beauty instrument control methods, in particular to a beauty instrument control method and system. According to the method, skin optical characteristics, biological impedance parameters and environmental parameters are acquired through multi-dimensional data acquisition, and a characteristic data set containing hemoglobin concentration, moisture content, real part of electrical impedance and environmental temperature is generated after preprocessing. Based on the data set, a multi-engine prediction model is adopted to analyze the skin state change trend, and predicted values of the moisture demand, the temperature sensitivity, the barrier function and the microcirculation state are generated. Then, optimization instructions of radio frequency energy, a phototherapy mode, micro-current parameters and temperature control are calculated respectively according to prediction results, and safety and coordination of parameter adjustment are ensured through cooperative verification. According to the invention, through dual-time scale prediction and multi-parameter collaborative optimization, the problem of nursing effect lag caused by environment change and skin state fluctuation of a traditional beauty instrument is solved, and the nursing precision and stability are significantly improved.
Owner:董全

Complement component C3 iRNA compositions and methods of use thereof

The present invention relates to RNAi agents, e.g., double stranded RNA (dsRNA) agents, targeting the complement component C3 gene (C3). The invention also relates to methods of using such RNAi agents to inhibit expression of a C3 gene and to methods of preventing and treating a C3-associated disorder, e.g., cold agglutinin disease (CAD), warm autoimmune hemolytic anemia, and paroxysmal nocturnal hemoglobinuria (PNH), lupis nephritis (LN), bullous pemphigoid, Pemphigus, e.g., Pemphigus vulgaris (PV) and Pemphigus foliaceus (PF), and C3 glomerulopathy.
Owner:ALNYLAM PHARMACEUTICALS INC

Fructus cannabis protein peptide capable of reducing blood sugar and regulating glycometabolism as well as preparation method and application of fructus cannabis protein peptide

The invention provides a fructus cannabis protein peptide capable of reducing blood sugar and regulating glycometabolism and a preparation method and application thereof, and belongs to the technical field of functional active peptides, and the preparation method comprises the following steps: performing low-temperature supersonic fluid crushing on fructus cannabis, performing enzymolysis pretreatment on the crushed fructus cannabis, adding compound protease for enzymolysis, adding PNGaseF enzyme for further enzymolysis, and performing freeze drying to obtain the fructus cannabis protein peptide capable of reducing blood sugar and regulating glycometabolism. And carrying out membrane ultrafiltration interception and enrichment on the enzymolysis supernatant, carrying out tangential flow filtration, concentrating, drying and sterilizing to obtain the fructus cannabis protein peptide. Tests prove that the novel fructus cannabis protein peptide has the following remarkable effects that the fasting blood glucose level can be remarkably reduced, and uncomfortable symptoms such as thirst, polydipsia, diuresis and weakness caused by hyperglycemia are relieved; the symptoms of glucose intolerance and insulin resistance caused by hyperglycemia can be obviously relieved, and the onset risk of type 2 diabetes mellitus is reduced; the level of fasting serum insulin and glycosylated hemoglobin can be obviously reduced, and the level of serum GLP-1 can be improved.
Owner:FINE GUANGZHOU BIOTECHNOLOGY CO LTD +1

Compositions and methods for treating anemias

The present disclosure relates to compositions and methods of increasing levels of fetal hemoglobin (HbF) in cells. The present disclosure further relates to methods for treating patients suffering from blood cell diseases, including those associated with reduced amounts of functional adult hemoglobin (HbA), such as sickle cell disease and β-thalassemias
Owner:FULCRUM THERAPEUTICS INC +1

Anti-hemoglobin antibody and application thereof

The invention discloses an anti-hemoglobin antibody and application thereof, and relates to the field of antibodies. The anti-hemoglobin antibody disclosed by the invention comprises a heavy chain complementarity determining region and a light chain complementarity determining region, provides an important raw material source for hemoglobin detection, and has good activity and sensitivity.
Owner:DONGGUAN PENGZHI BIOTECH CO LTD

Method and system for predicting hemoglobin concentration of postoperative patient

The invention relates to a postoperative patient hemoglobin concentration prediction method and system. The method comprises the following steps: acquiring basic information and physical examination data of a patient; inputting the basic information and the physical examination data of the patient into the target classification prediction model to obtain a hemoglobin concentration prediction result of the patient; the target classification prediction model is a classification prediction model of which model parameters are determined after multiple machine learning algorithm models are trained and evaluated based on sample data sets of multiple cases in advance and meet preset conditions, and the machine learning algorithm model corresponding to the target classification prediction model comprises an extreme gradient boosting tree model; the construction of the sample data set comprises the steps that multiple pieces of original case data of multiple sample cases are obtained, preprocessing, namely data missing value filling and / or sample equalization processing is carried out on the multiple pieces of original case data, and data missing value filling adopts a fusion filling method; according to the method, the relationship between the same feature data of different cases and the relationship between different feature data of the same case are considered at the same time.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Recombinant escherichia coli for producing NMN through fermentation and application of recombinant escherichia coli

The invention discloses recombinant escherichia coli for producing NMN through fermentation and application of the recombinant escherichia coli, and belongs to the technical field of genetic engineering and biological engineering. According to the invention, nicotinamide phosphoribosyltransferase NAMPT, PRPP synthase BaPRS, transport protein BMpnuC, glucose-6-phosphate 1-dehydrogenase EcZwf, 6-phosphogluconate dehydrogenase EcGnd, fructose-1, 6-diphosphatase II EcGlpX, vitreous hemoglobin enzyme Vhb and NADH transhydrogenase EcSthA are expressed in Escherichia coli, and a pncC gene, a ushA gene, an nadR gene, a purR gene, a pncA gene, an edd gene, an gntR gene, a pfkA gene and a pntAB gene are knocked out, so that the recombinant plasmid is obtained. The accumulation amount of NMN in escherichia coli cells is increased, and fermentation conditions are further optimized, so that the strain can obtain more than 4.9 g / L of NMN at a shake flask level.
Owner:JIANGNAN UNIV

Neonatal jaundice health management system based on big data

The invention discloses a neonatal jaundice health management system based on big data, and belongs to the technical field of jaundice health management, and the system specifically comprises the steps: collecting the transdermal jaundice measurement value, hemoglobin concentration, day age and weight data of a neonate through a data collection module; an individualized drift index is calculated based on the hemoglobin concentration and the day age data through a physiological parameter calibration module; inputting the transdermal jaundice measurement numerical value and the individualized drift index into a dynamic correction model through a dynamic prediction analysis module to generate a serum bilirubin prediction numerical value; a time sequence data processing module is used for smoothing the predicted numerical value and calculating the variable quantity of adjacent time points; constructing trend indexes and generating serum bilirubin change trend data through a trend analysis and detection module; and finally, generating a health management scheme based on the threshold level and the trend change point through an intelligent decision module. According to the invention, effective assessment and personalized management of the neonatal jaundice risk are realized.
Owner:FUJIAN PROVINCIAL HOSPITAL

Near-infrared super-scanning-based nursing efficiency evaluation method and system

The invention belongs to the technical field of brain function testing, and particularly discloses a nursing effectiveness evaluation method and system based on near-infrared super-scanning, and the method comprises the steps: synchronously obtaining light intensity data of a forehead lobe cortex, a parietal lobe cortex and an occipital lobe cortex of a subject during a cooperative cognitive task jointly executed by the subject and a caregiver through a near-infrared brain function imaging fNIRS system; converting into oxygenated and deoxidized hemoglobin concentration, and then carrying out individual level analysis; completing brain region matching, and detecting intercerebral synchronous activity through transfer entropy analysis and joint power spectrum analysis to obtain the size and directivity of intercerebral synchronism; and according to the magnitude and directivity of the inter-brain synchronism, evaluating the level of the care efficiency between the cognitive impairment patient and the caregiver. According to the technical scheme, the hyperscanning technology is applied, the grade of the nursing efficiency between the cognitive impairment patient and the caregiver is obtained through analysis, and therefore the cognitive impairment patient can be conveniently and emphatically observed and nursed.
Owner:CHONGQING MEDICAL UNIVERSITY

Compositions and methods for editing beta-globin for treatment of hemaglobinopathies

The disclosure features systems and methods for correcting a mutation in the human beta-globin (HBB) gene in a cell or population of cells. The disclosure also features methods of increasing repair of a DNA double stranded break (DSB) in an HBB gene by the homology-directed repair (HDR) pathway. The disclosure also features compositions for use in the methods.
Owner:VERTEX PHARMACEUTICALS INC

Improved globin and other lentiviral vectors for gene therapy

PCT designated stage expiredWO2025151744A1VectorsHaemoglobins/myoglobinsCoboglobinExpression cassette
The present subject matter relates to recombinant lentiviral transfer plasmids for producing lentiviral vectors with increased vector titer and performance. These transfer plasmids are constructed so that a central polypurine tract (cPPT) is centered between the lentiviral LTRs and include a 6x stop codon sequence block downstream of the 3' LTR. When the transfer plasmids comprise a globin expression cassette, the lentiviral vectors produced therefrom are useful for treating hemoglobinopathies by gene therapy. Transduced cells, pharmaceutical compositions and methods of treating or ameliorating hemoglobinopathies with these lentiviral vectors are also provided. Additional transfer plasmids, cells, and compositions are provided that are useful for delivering any gene of interest to a cell, as well as plasmids for production of lentiviral vectors for treating other erythroid-specific diseases or disorders such as anemia and cancer.
Owner:UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION +1

Application of EPO source peptide in preparation of medicine for treating pulmonary fibrosis

The invention discloses an application of an EPO source peptide in preparation of a medicine for treating pulmonary fibrosis, the EPO source peptide is used for treating bleomycin-induced pulmonary fibrosis mice, pulmonary fibrosis lesions of the mice are remarkably improved, and weight reduction and mortality increase of the mice are also remarkably improved. Meanwhile, the number of red blood cells, the hemoglobin content, the red blood cell distribution width variable coefficient and pulmonary vascular embolism of mice treated by the EPO source peptide have no significant difference compared with those of a control group, which indicates that the EPO source peptide treatment can significantly improve the pulmonary fibrosis lesion of the mice with pulmonary fibrosis, and has no side effect. The whole condition of a pulmonary fibrosis patient can be improved, the death rate is remarkably reduced, and a potential new medicine is provided for treatment of IPF.
Owner:ARMY MEDICAL UNIV

Anemia blood transfusion risk management system based on real-time monitoring

The invention relates to an anemia blood transfusion risk management system based on real-time monitoring, and belongs to the technical field of medical data processing. The management system comprises a plurality of sensors and is used for acquiring multiple monitoring data such as hemoglobin concentration, blood oxygen saturation waveform and cardiovascular waveform of a patient, and real-time analysis is executed by a calculation module. The calculation module quantifies key indexes such as blood volume change and hemoglobin concentration by constructing a dynamic risk index model, and performs morphological similarity comparison on a real-time waveform and a plurality of established reference waveform templates. And the management system corrects the risk level based on the similarity analysis result and outputs a comprehensive score. The score can be used as a reference standard for clinical blood transfusion intervention.
Owner:MUDANJIANG MEDICAL UNIV

FNIRS adaptive feedback emotion cognition cooperative training device and method

The invention discloses an fNIRS adaptive feedback emotion cognition cooperative training device and method, and relates to the technical field of emotion disorder cognition training. The device comprises a data acquisition module used for acquiring an original dual-wavelength light intensity signal from a brain; the data processing module is used for performing multi-stage preprocessing on the original dual-wavelength light intensity signal; the neural feedback module is used for calculating a multi-dimensional evaluation index according to the hemoglobin concentration data and adjusting a difficulty level and a feedback threshold value of a training task by using a dynamic threshold value control algorithm; the training module is used for training participants based on the emotion stimulation task and the cognitive training task; and the evaluation module is used for performing training evaluation according to the comparison result of the comprehensive performance score and the feedback threshold. Brain function equipment is closely combined with cognitive training and emotion stimulation tasks, dynamic evaluation and real-time feedback are added for traditional tasks, and through the brain network analysis technology, accurate evaluation of the user training effect is achieved.
Owner:SHANDONG UNIV

COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF

The invention relates to iRNA, e.g., double-stranded ribonucleic acid (dsRNA), compositions targeting the complement factor B (CFB) gene, the complement component C3 gene, and the complement component C9 gene and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of CFB, C9 and / or C3 and to treat subjects having a complement component-associated disease, e.g., paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Owner:ALNYLAM PHARMACEUTICALS INC

Nano-drug for treating idiopathic pulmonary fibrosis as well as preparation method and application of nano-drug

The invention relates to the technical field of biological medicines, in particular to a nano-drug for treating idiopathic pulmonary fibrosis as well as a preparation method and application of the nano-drug. The nano-particles are prepared by loading the TGF-beta1 inhibitor and the RSV by using hemoglobin, so that the TGF-beta1 inhibitor and the RSV are cooperated to effectively treat idiopathic pulmonary fibrosis.
Owner:SHENZHEN CHILDRENS HOSPITAL

Application of colla corii asini bone-strengthening oral liquid in preventing and / or treating anemia

PendingCN119792413AMetabolism disorderPharmaceutical delivery mechanismUrea nitrogen/CreatinineSerum iron
The invention discloses application of colla corii asini bone-strengthening oral liquid to prevention and / or treatment of anemia, and belongs to the technical field of medicines, and the anemia comprises iron-deficiency anemia, renal anemia and myelosuppression anemia. The colla corii asini bone strengthening oral liquid can increase erythrocyte count, hemoglobin concentration, hematocrit, erythrocyte average hemoglobin amount, erythrocyte average hemoglobin concentration and / or erythrocyte average volume; the serum iron content is increased; a transporter divalent metal transporter and a membrane iron transporter are increased; the intestinal iron absorption is promoted. The composition specifically comprises urea nitrogen and creatinine; related indexes of renal anemia are improved; the immune index of renal anemia can be improved. The percentage of leukocytes and lymphocytes of anemia caused by myelosuppression can be recovered; the hemoglobin content is increased; the number of macrophage colony stimulating factors and / or bone marrow cells in serum is increased; the immunocompetence is improved; the proliferation of lymphoid B cells and macrophages is promoted.
Owner:XINJIANG HUASHIDAN PHARMA

Acute radiodermatitis risk prediction method and system

The invention discloses an acute radiodermatitis prediction method and system, the method comprises an optical imaging system and a machine learning prediction model, the optical system realizes image acquisition of a treatment area of a radiotherapy patient based on a spatial frequency domain imaging (SFDI) technology, dynamically monitors quantitative optical and physiological indexes of the skin of the patient in a radiotherapy treatment course, and determines whether the patient is in the radiotherapy treatment course or not. Comprise hemoglobin concentration, oxygen saturation, melanin concentration, reduced scattering coefficient and the like. The prediction module comprehensively considers three aspects of individual differences (clinical features) of patients, radiotherapy parameters (dosiomics features) and skin optical and physiological indexes obtained by an optical system, and constructs a prediction model by applying a machine learning algorithm to realize accurate prediction of acute radiodermatitis. The method solves the problems that clinical evaluation of acute radiodermatitis mainly depends on experience judgment of doctors at present, and scientific and systematic prediction methods and tools are lacked.
Owner:THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIV

Complement component C5 iRNA compositions and methods of use thereof

The present invention relates to iRNA, such as double-stranded ribonucleic acid (dsRNA), compositions targeting complement component C5 gene and methods of using such iRNA (e.g., dsRNA), compositions to inhibit the expression of C5 and treat subjects suffering from a complement component C5-associated disease (e.g., paroxysmal nocturnal hemoglobinuria).
Owner:ALNYLAM PHARMACEUTICALS INC

Handheld opto-acoustic multi-mode vascular puncture and tissue damage diagnosis system and device

The invention provides a handheld photoacoustic multi-mode vascular puncture and tissue damage diagnosis system and device, and belongs to the technical field of photoacoustic imaging. According to the handheld multispectral photoacoustic imaging device, elastic force feedback and blood vessel real-time development are integrated, and the puncture success rate is increased by 30%; by virtue of hemoglobin / collagen double-index imaging, the stress injury can be pre-warned 72 hours in advance; the 3D hematoma volume automatically calculates an error lt; and repeated puncture and missed diagnosis are remarkably reduced. The invention provides a quantitative evaluation and real-time navigation integrated scheme for vascular puncture and tissue damage, and is safe and efficient.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV